177 related articles for article (PubMed ID: 28658153)
1. Bmi-1 overexpression as an efficient prognostic marker in patients with nonsmall cell lung cancer.
Zhang X; Tian T; Sun W; Liu C; Fang X
Medicine (Baltimore); 2017 Jun; 96(26):e7346. PubMed ID: 28658153
[TBL] [Abstract][Full Text] [Related]
2. Prognostic role of B7-H4 in patients with non-small cell lung cancer: A meta-analysis.
Tan Z; Shen W
Oncotarget; 2017 Apr; 8(16):27137-27144. PubMed ID: 28404927
[TBL] [Abstract][Full Text] [Related]
3. Prognostic value of angiopoietin-2 in non-small cell lung cancer patients: a meta-analysis.
Xuan ZX; Zhang S; Yuan SJ; Wang W; Yu J
World J Surg Oncol; 2016 Sep; 14(1):237. PubMed ID: 27589869
[TBL] [Abstract][Full Text] [Related]
4. Prognostic value of CD44 expression in non-small cell lung cancer: a systematic review.
Luo Z; Wu RR; Lv L; Li P; Zhang LY; Hao QL; Li W
Int J Clin Exp Pathol; 2014; 7(7):3632-46. PubMed ID: 25120740
[TBL] [Abstract][Full Text] [Related]
5. Nestin is significantly associated with the overall survival of nonsmall cell lung cancer: A meta-analysis.
Zhang D; Wang J
J Cancer Res Ther; 2020; 16(4):800-803. PubMed ID: 32930121
[TBL] [Abstract][Full Text] [Related]
6. Prognostic impact of elevation of vascular endothelial growth factor family expression in patients with non-small cell lung cancer: an updated meta-analysis.
Zheng CL; Qiu C; Shen MX; Qu X; Zhang TH; Zhang JH; Du JJ
Asian Pac J Cancer Prev; 2015; 16(5):1881-95. PubMed ID: 25773840
[TBL] [Abstract][Full Text] [Related]
7. Prognostic and clinicopathological significance of long noncoding RNA MALAT-1 expression in patients with non-small cell lung cancer: A meta-analysis.
Liu X; Huang G; Zhang J; Zhang L; Liang Z
PLoS One; 2020; 15(10):e0240321. PubMed ID: 33052949
[TBL] [Abstract][Full Text] [Related]
8. Prognostic and clinicopathological value of osteopontin expression in non-small cell lung cancer: a meta-analysis and systematic review.
Song Y; Li H; Jiang Q; Wu L
Biomarkers; 2024 Mar; 29(2):105-113. PubMed ID: 38376506
[TBL] [Abstract][Full Text] [Related]
9. A meta-analysis for CXCR4 as a prognostic marker and potential drug target in non-small cell lung cancer.
Zhang C; Li J; Han Y; Jiang J
Drug Des Devel Ther; 2015; 9():3267-78. PubMed ID: 26150700
[TBL] [Abstract][Full Text] [Related]
10. Podoplanin is a useful prognostic marker and indicates better differentiation in lung squamous cell cancer patients? A systematic review and meta-analysis.
Hu L; Zhang P; Mei Q; Sun W; Zhou L; Yin T
BMC Cancer; 2020 May; 20(1):424. PubMed ID: 32408907
[TBL] [Abstract][Full Text] [Related]
11. Expression patterns of USP22 and potential targets BMI-1, PTEN, p-AKT in non-small-cell lung cancer.
Hu J; Liu YL; Piao SL; Yang DD; Yang YM; Cai L
Lung Cancer; 2012 Sep; 77(3):593-9. PubMed ID: 22717106
[TBL] [Abstract][Full Text] [Related]
12. The clinicopathologic impacts and prognostic significance of GLUT1 expression in patients with lung cancer: A meta-analysis.
Zhang B; Xie Z; Li B
Gene; 2019 Mar; 689():76-83. PubMed ID: 30552981
[TBL] [Abstract][Full Text] [Related]
13. The prognostic value of CD133 expression in non-small cell lung cancer: a meta-analysis.
Wang W; Chen Y; Deng J; Zhou J; Zhou Y; Wang S; Zhou J
Tumour Biol; 2014 Oct; 35(10):9769-75. PubMed ID: 24973892
[TBL] [Abstract][Full Text] [Related]
14. Prognostic value of CD44 variant exon 6 expression in non-small cell lung cancer: a meta-analysis.
Zhao S; He JL; Qiu ZX; Chen NY; Luo Z; Chen BJ; Li WM
Asian Pac J Cancer Prev; 2014; 15(16):6761-6. PubMed ID: 25169522
[TBL] [Abstract][Full Text] [Related]
15. Overexpression of forkhead box M1 is associated poor survival in patients with nonsmall cell lung cancer.
Liu B; Su F; Lin R; Teng H; Ju Y
J Cancer Res Ther; 2018 Dec; 14(Supplement):S1121-S1123. PubMed ID: 30539856
[TBL] [Abstract][Full Text] [Related]
16. [Relationship between MTA1 Expression and Prognosis of Chinese Lung Cancer
Patients: A Meta-analysis].
Zhong H; Tang Y; Wang Y; Gu W
Zhongguo Fei Ai Za Zhi; 2017 Oct; 20(10):683-689. PubMed ID: 29061215
[TBL] [Abstract][Full Text] [Related]
17. The clinicopathological and prognostic value of CXCR4 expression in patients with lung cancer: a meta-analysis.
Qiu L; Xu Y; Xu H; Yu B
BMC Cancer; 2022 Jun; 22(1):681. PubMed ID: 35729596
[TBL] [Abstract][Full Text] [Related]
18. The association of melanoma-associated antigen-A gene expression with clinicopathological characteristics and prognosis in resected non-small-cell lung cancer: a meta-analysis.
Wang Y; Lu Y; Li J; Wu Y; Che G
Interact Cardiovasc Thorac Surg; 2019 Dec; 29(6):855-860. PubMed ID: 31384932
[TBL] [Abstract][Full Text] [Related]
19. Prognostic significance of NF-κB expression in non-small cell lung cancer: A meta-analysis.
Gu L; Wang Z; Zuo J; Li H; Zha L
PLoS One; 2018; 13(5):e0198223. PubMed ID: 29813121
[TBL] [Abstract][Full Text] [Related]
20. Overexpression of B7-H3 correlates with aggressive clinicopathological characteristics in non-small cell lung cancer.
Wu S; Zhao X; Wu S; Du R; Zhu Q; Fang H; Zhang X; Zhang C; Zheng W; Yang J; Feng H
Oncotarget; 2016 Dec; 7(49):81750-81756. PubMed ID: 27835582
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
